Breaking News

CureVac struggles to build up its vaccine stock

Even though its serum is still being studied by health authorities, the German laboratory says it is encountering supply problems, accusing the United States of blocking the export of certain components. A situation that could undermine European vaccination campaigns.

Even though its serum is still being studied by health authorities, the German laboratory says it is encountering supply problems, accusing the United States of blocking the export of certain components. A situation that could undermine European vaccination campaigns.

(AFP) – The race for vaccination is experiencing a new setback on a European scale. So in an interview with the German magazine Der Spiegel, Franz-Werner Haas indicated that his laboratory, CureVac, “no longer regularly received the materials necessary” for the composition of its anti-covid vaccine. And this even though this serum has not yet been approved by European health authorities.

According to the general manager of CureVac, the components would be blocked by the United States. An argument also put forward by its competitor, the Anglo-Swedish laboratory AstraZeneca, to justify the delivery delays in recent weeks.

The admission of Franz-Werner Haas who stresses that his group lives “from day to day” and struggles to constitute “an important stock”, is worrying for the European Union which wants to vaccinate 70% of its adult nationals against the covid d ‘here in July.

Without being essential for this purpose, the vaccine from CureVac could provide significant help. If its trials are only due in a few weeks, the EU has already made a big bet on it since it has ordered more than 400 million doses. Of this first order, some 310,000 must be delivered to Luxembourg.

Especially since several of the EU’s suppliers are late in their initial deliveries, notably Johnson & Johnson and AstraZeneca, against which the European Commission has taken legal action. Of the 180 million doses it was to deliver to the EU, the laboratory will only be able to honor 70 million.

In Luxembourg, Prime Minister Xavier Bettel (DP) has not expressed any particular expectations for this German vaccine. By the end of June, health authorities are counting on the delivery of 243,000 doses of Pfizer, 48,800 Moderna, 9,400 Johnson & Johnson, and 8,600 AstraZeneca.


Tags

Related Articles

Back to top button
Close
Close